Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription

[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

Re: Permax post#1

Subject:        Re: Permax


I will ask the Permax team to respond to your question. Simply, pergolide is
off patent in most global markets. Part of the reason the costs may seem
relatively high are the associated manufacturing costs which exceed the
Lilly norm. Future directions in Parkinson's research rest in early phase
clinical development and encompass a new platform approach based on the
so-called "excitatory amino acids" in brain. Good luck.
Note: Mr. Tollefson is the Director of Neurosciences at Eli Lilly

Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance